CLINICAL_TRIALS ClinicalTrials.gov record update

Etude de l'Effet de l'Horaire de Perfusion de l'immunothérapie Sur la réponse et la toxicité Des Traitements Chez Les Patientes Atteintes de Cancer du Sein Triple négatif à Haut Risque traité Par chimiothérapie néoadjuvante et Pembrolizumab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06418139
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:31.385385+00:00
Published At: 2024-05-16T00:00:00+00:00
Record Updated At: 2024-05-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-Metastatic Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-05-16"
protocolSection.identificationModule.nctId: "NCT06418139"
protocolSection.identificationModule.officialTitle: "Etude de l\u0027Effet de l\u0027Horaire de Perfusion de l\u0027immunoth\u00e9rapie Sur la r\u00e9ponse et la toxicit\u00e9 Des Traitements Chez Les Patientes Atteintes de Cancer du Sein Triple n\u00e9gatif \u00e0 Haut Risque trait\u00e9 Par chimioth\u00e9rapie n\u00e9oadjuvante et Pembrolizumab"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.